Table 1. Patients’ characteristics.
| Patients’ characteristics | Total cohort (n = 283) | Subcohort (n = 163) |
|---|---|---|
| Age, years (median and range) | 58 (19–86) | 57 (19–86) |
| Sex (female | male) | 118 | 165 | 66 | 97 |
| Disease stage at diagnosis | ||
| Chronic phase | a | 119 (73.0%) |
| Accelerated phase | a | 8 (4.9%) |
| Blast phase | a | 3 (1.8%) |
| Follow-up (months; median and range) | a | 63.2 (2.3–377.2) |
| TKI treatment duration (months; median and range) | a | 62.4 (2.1–177.9) |
| Best available response (number) | ||
| No MMR | a | 50 (30.7%) |
| MMR | a | 26 (16.0%) |
| MR4 | a | 31 (19.0%) |
| MR4.5 | a | 27 (16.6%) |
| MR5 | a | 29 (17.8%) |
a
Not available. MR, molecular response, MMR, mean molecular response.